Tags |
|
|
Links |
|
|
Main Subject - De-Mystifying the Medical Billing Maze
Medical billing can follow a very complex and strange process. For those who don’t or haven’t actually worked as d
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
octors, or for insurance companies, the procedures can be quite opaque, but fundamentally it is quite simple.
Whe
Whe
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
n a patient goes to a medical provider for surgery or to be put on medication, or simply to diagnose conditions th
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
patient has been experiencing, there are certain costs for each service the medical practitioner provides to the
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
patient. The provider records these costs in a form, usually a HCFA, or “hic-fuh,” which can be either electronic
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
r paper. The HCFA is then sent to the patient’s insurance company, or sometimes to a clearinghouse or other middle
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
man that can process the claim. When processing a claim, the insurance company looks at how valid the charges that
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
the provider put on the claim are. Different companies have different systems for determining this, but in genera
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
it can be expected that about half the charges the provider put on the claim will be paid by the insurer, and hal
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
f by the patient. Things like a deductible, co-pay, and coinsurance can have a heavy bearing on how much the insur
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
r is willing to pay. If the patient has coinsurance, for instance, the insurance company is obligated to pay for a
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
certain percentage of all the charges on the medical bill.
When the insurer has decided which charges are valid
When the insurer has decided which charges are valid
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
it returns the claim to the medical provider, in either electronic or paper format depending on their customs. Onc
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
received the medical provider looks at and analyzes the claim to see what the insurer has agreed to pay. If none
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
of the charges were rejected by the insurer the provider then they will soon pay all the charges on the bill. If a
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
y charges were rejected, the provider must make changes to the bill and then return it to the insurer. If, once re
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
turned, the information on the bill is accurate the insurance company will pay it. But as with before, it might re
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ject some of the charges, and if so the bill will be returned to the provider, and so on until the provider submit
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
a medical claim the insurer can agree to pay the charges for.
Once the insurance company has agreed to pay for a
Once the insurance company has agreed to pay for a
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ll the charges the provider has listed it falls on the provider to go to the patient to collect any unpaid charges
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/2433/mainsubjects-DeMystifying-the-Medical-Billing-Maze.html">De-Mystifying the Medical Billing Maze</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/2433/mainsubjects-DeMystifying-the-Medical-Billing-Maze.html]De-Mystifying the Medical Billing Maze[/url]
Related Articles:
Top 3 Reasons For Writing Business Plans
Small Business Ideas for Working at Home
Bookmark it:
|